Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Operating Leases, Rent Expense, Net

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Operating Leases, Rent Expense, Net

Co-Diagnostics, Inc. (CODX) reported Operating Leases, Rent Expense, Net of $42.26 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingLeasesRentExpenseNet · last filed 2019-11-12

  • Co-Diagnostics, Inc. operating leases, rent expense, net for the quarter ending 2019-09-30 was $42.26K, a 9.20% decline year-over-year.
  • Co-Diagnostics, Inc. operating leases, rent expense, net for the quarter ending 2019-06-30 was $45.04K, a 19.38% increase year-over-year.
  • Co-Diagnostics, Inc. operating leases, rent expense, net for the quarter ending 2019-03-31 was $45.58K, a 20.28% increase year-over-year.
  • Co-Diagnostics, Inc. operating leases, rent expense, net for the quarter ending 2018-12-31 was $43.98K, a 414.46% increase year-over-year.
  • Co-Diagnostics, Inc. operating leases, rent expense, net for fiscal 2018 was $166.15K, a 212.70% increase from fiscal 2017.
  • Co-Diagnostics, Inc. operating leases, rent expense, net for fiscal 2017 was $53.13K.
Period endOperating Leases, Rent Expense, Net 3 monthOperating Leases, Rent Expense, Net 3 month as first filedOperating Leases, Rent Expense, Net 6 monthOperating Leases, Rent Expense, Net 6 month as first filedOperating Leases, Rent Expense, Net 9 monthOperating Leases, Rent Expense, Net 12 month
2019-09-30$42.26K
10-Q · filed 2019-11-12
$87.30K
derived: sum of 2 quarters · filed 2019-11-12
$132.88K
10-Q · filed 2019-11-12
$176.86K
derived: sum of 4 quarters · filed 2019-11-12
2019-06-30$45.04K
10-Q · filed 2019-08-14
$90.62K
10-Q · filed 2019-08-14
$134.60K
derived: sum of 3 quarters · filed 2019-08-14
$181.14K
derived: sum of 4 quarters · filed 2019-11-12
2019-03-31$45.58K
10-Q · filed 2019-05-14
$89.56K
derived: sum of 2 quarters · filed 2019-05-14
$136.10K
derived: sum of 3 quarters · filed 2019-11-12
$173.83K
derived: sum of 4 quarters · filed 2019-11-12
2018-12-31$43.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$90.52K
derived: sum of 2 quarters · filed 2019-11-12
$128.25K
derived: sum of 3 quarters · filed 2019-11-12
$166.15K
10-K · filed 2019-04-01
2018-09-30$46.54K
10-Q · filed 2019-11-12
$46.54K
10-Q · filed 2018-11-14
$84.27K
derived: sum of 2 quarters · filed 2019-11-12
$122.17K
10-Q · filed 2019-11-12
$130.72K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$37.73K
10-Q · filed 2019-08-14
$75.63K
10-Q · filed 2019-08-14
$75.63K
10-Q · filed 2018-08-10
$84.17K
derived: sum of 3 quarters · filed 2019-08-14
$103.08K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$37.90K
10-Q · filed 2019-05-14
$46.45K
derived: sum of 2 quarters · filed 2019-05-14
$65.35K
derived: sum of 3 quarters · filed 2019-05-14
$79.68K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$8.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$27.45K
derived: sum of 2 quarters · filed 2019-04-01
$41.79K
derived: sum of 3 quarters · filed 2019-04-01
$53.13K
10-K · filed 2019-04-01
2017-09-30$18.90K
10-Q · filed 2018-11-14
$33.24K
derived: sum of 2 quarters · filed 2018-11-14
$44.58K
10-Q · filed 2018-11-14
2017-06-30$14.34K
10-Q · filed 2018-08-10
$25.68K
10-Q · filed 2018-08-10
2017-03-31$15.13K
10-Q · filed 2018-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01